Inventor
Michael D. Wendt
Inventor
Vernon Hills, IL, US
Overview
Patents· 46 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes20%
C07CAcyclic or carbocyclic compounds12%
Y02ATechnologies for adaptation to climate change3%
C07BGeneral methods of organic chemistry1%
C04BLime, magnesia1%
PatentTitleYear
10,676,485Macrocyclic MCL-1 inhibitors and methods of use202010,081,628Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases20189,877,958'Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases'20189,844,547Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases20179,561,231'Pyridinone and pyridazinone derivatives'20179,315,488'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20169,303,025'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20169,266,877'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20169,227,963'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20169,174,982'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,156,856'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,125,913'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,072,748'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,073,855'BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,045,420'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,045,444'Apoptosis promoters'20158,952,157'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20158,940,737'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20158,889,675'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20148,686,136'Apoptosis promoters'20148,614,318'Apoptosis promoters'20138,586,754'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20138,563,735'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20138,546,399'Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,426,422'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,354,404'Apoptosis promoters'20138,343,967'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,338,466'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20128,188,077'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20128,173,811'Apoptosis promoters'20128,084,607'Apoptosis promoters'20117,989,656'Biaryl carboxylic acid apoptosis promoters'20117,973,161'Apoptosis promoters'20117,910,742'Survivin inhibitors'20117,767,684'Apoptosis promoters'20107,754,886'N-acylsulfonamide apoptosis promoters'20107,750,004'Apoptosis promoters'20107,642,260'Apoptosis promoters'20107,504,512'N-acylsulfonamide apoptosis promoters'20096,720,338'N-acylsulfonamide apoptosis promoters'20046,376,488'Benzoxazine -1 adrenergic compounds'20026,284,796'Ukokinase inhibitors'20016,258,822'Urokinase inhibitors'20016,046,207'Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adrenergic compounds'20005,891,882'Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adenergic compounds'19995,597,823'Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2013Patents assigned to ABBOTT LAB (20)· patent assignee history
1997–2001Based in North Chicago, IL, US· patent location history
2001Based in Deerfield, IL, US· patent location history
2002–2020Based in Vernon Hills, IL, US· patent location history
2011–2013Patents assigned to DING HONG (10)· patent assignee history
2011–2013Patents assigned to PARK CHEOL-MIN (9)· patent assignee history
2011–2013Patents assigned to SONG XIAOHONG (8)· patent assignee history
2013–2020Patents assigned to ABBVIE INC (25)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBVIE INC | 25 | 2013–2020 |
| ABBOTT LAB | 20 | 1997–2013 |
| DING HONG | 10 | 2011–2013 |
| PARK CHEOL-MIN | 9 | 2011–2013 |
| SONG XIAOHONG | 8 | 2011–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Vernon Hills, Illinois, US | 41 | 2002–2020 |
| North Chicago, Illinois, US | 4 | 1997–2001 |
| Deerfield, Illinois, US | 1 | 2001 |